免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

PubMed

Three-Dimensional Printing: A Catalyst for a Changing Orthopaedic Landscape.

PMID: 32224627 · 2020

J, o, n, a, t, h, a, n, , M, i, n, t, o, ;, , X, u, a, n, , Z, h, o, u, ;, , J, e, n, n, a, , O, s, b, o, r, n, ;, , L, i, j, i, e, , G, r, a, c, e, , Z, h, a, n, g, ;, , K, a, u, s, i, k, , S, a, r, k, a, r, ;, , R, a, j, , D, , R, a, o

学術誌JBJS reviews
年2020
PMID32224627

抄録

Three-dimensional (3D) printing is an emerging tool in provider and patient education, surgical planning, and the design and implementation of medical devices and implants. Recent decreases in the cost of 3D printers along with advances in and cost reduction of printable materials have elevated 3D printing within the medical device industry. The advantages of 3D printing over traditional means of implant manufacturing lie in its ability to use a wide array of materials, its fine control of the m

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。

↑